At 8 pm on April 9, 2012, the CCTV News Channel "Oriental Space-Time" column reported the first case of "targeted cellular immunotherapy" in Northeast China, marking the promise of ACTL targeted cellular immunotherapy. Promotion in tumor treatment.

         At 10 am on April 11, 2012, Shenzhen Yishi Kangning Biotechnology Co., Ltd. held a grand opening ceremony and officially settled in Yuanzheng Innovation Building.          ISKCON will scientifically and standardizedly develo...

The company provides comprehensive, systematic and professional support in terms of the joint construction of tumor biotherapy laboratories, clinical scientific research project cooperation, biotherapy technology training and guidance, technology and clinical application promotion, and scientific r...

        On February 9, 2012, two technicians Sadhna and Tanvi from Beike India branch came to our company to learn ACTL technology. We conducted three weeks of theoretical and operational training on this.        The training process is mainly divi...